Law360, New York (August 30, 2011, 1:24 PM ET) -- Pfizer Inc. on Monday settled a patent infringement suit lodged in Delaware federal court against Dr. Reddy’s Laboratories Ltd. over its plans to produce a generic version of the blockbuster anti-cholesterol drug Lipitor.
U.S. District Judge Leonard P. Stark signed off on a joint motion dismiss the case without prejudice, ending a lawsuit that alleged Dr. Reddy’s abbreviated new drug application for a generic version of Lipitor infringed Pfizer’s patent covering the medication.
Under an agreement entered into Aug. 19, the litigation was put to rest...
Pfizer Settles Lipitor Patent Suit Against Dr. Reddy's
To view the full article, take a free trial now.
